Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2025 May 30:2025.05.29.656939. [Version 1] doi: 10.1101/2025.05.29.656939

Comparative Evaluation of Three Calcium Silicate-Based Materials for Direct Pulp Capping: An In Vivo Study in Mice

Fatma Fenesha 1, Aonjittra Phanrungsuwan 1, Dane Kanniard 1, Brian L Foster 1, Anibal Diogenes 2, Sarah B Peters 1
PMCID: PMC12155004  PMID: 40502177

Abstract

Introduction:

Vital pulp treatments (VPT) aim to conservatively manage deep caries and/or damage to preserve the vitality and function of the pulp. This minimally invasive approach is still debated when performing direct pulp capping (DPC), a treatment in which a protective biocompatible material is directly placed over the dental pulp, due to microbial risks inherent with pulp exposure and difficulties in sealing the exposure to protect the pulp from subsequent bacterial ingress. Several limitations associated with Mineral Trioxide Aggregate (MTA) such as long setting time and discoloration have promoted the development of next-generation MTA derivatives with enhanced physical, chemical, and biological properties. As these materials are relatively new, existing studies are limited in scope, lacking a comprehensive assessment of both reparative dentin formation and the sealing ability, which are critical parameters for determining long-term clinical success. These assessments require preclinical models, and while the mouse model offers the opportunity to explore the molecular mechanisms guiding reparative dentinogenesis, the materials and techniques optimized for human dentition present technical challenges in mice due to their small size.

Aim:

We aimed to optimize a DPC technique to use in mice by comparing the tissue responses and the sealing ability of three calcium silicate capping agents: Bioceramic putty (BC), Biodentine (BD), and Theracal-LC (TLC) to a control material known to seal well but cause desiccation that would lead to tissue damage; Cavit-G (CG).

Material and methods:

DPC was performed on the maxillary first molar of C57BL/6 female mice. Reparative dentin was assessed with micro-computed tomography (micro-CT) and histological assessment of dentin bridge formation at 21 days. The sealing ability of the capping materials was evaluated using micro-CT.

Results:

All three calcium silicate materials showed good biocompatibility and the ability to form a dentin bridge. Micro-CT quantifications of material voids demonstrated superior seals with bioceramic putty and Theracal-LC groups as compared to Biodentine.

Conclusions:

Ready-to-use, premixed capping agents exhibit better sealing ability in mice, while promoting dentin bridge formation to protect the dental pulp.

Keywords: Direct pulp capping, reparative dentin, calcium silicate, microleakage

Introduction:

Dental caries (tooth decay) is one of the most common chronic diseases worldwide [1, 2], affecting people of all ages with a prevalence of 46.2% in primary teeth and 53.8% in permanent teeth [13]. The dental pulp is the innermost part of the tooth, a soft connective tissue that consists of nerves, blood vessels, and a wide array of cells. It plays a critical role in tooth formation, sensation, nutrition, and repair, and it ensures the long-term health of the tooth [4]. When the pulp is healthy, it keeps the tooth alive and functional. However, if the pulp becomes damaged or infected due to deep caries, trauma, or other factors, it can lead to pulp inflammation or pulpitis. Management of deep caries lesions, in which the infection extends close to or deep into the pulp, depends on the stage of inflammation (reversible or irreversible pulpitis) and requires careful planning to preserve tooth vitality and prevent the recurrence of the infection [58]. Currently, the most widely used treatment modality for pulpitis in adults is root canal therapy (RCT), which involves completely removing and replacing the dental pulp with a root canal sealing material. While this method has proven effective in addressing pulp inflammation and saving the tooth, it comes with certain limitations. It may render the tooth brittle in the absence of its natural pulp and blood supply, both of which are crucial for maintaining vitality and flexibility. Furthermore, if the root canal is not properly sealed or if the restoration leaks, bacteria can re-enter the tooth, causing reinfection, leading to apical periodontitis or abscess formation [9, 10]. Due to the growing recognition of the crucial function of dental pulp, modern dentistry is increasingly focusing on preserving the vitality of this tissue, reflecting a shift from conventional RCT to less invasive dental procedures such as VPT [1113].

The American Association of Endodontists defines VPT as “a treatment that preserves and maintains pulp tissue that has been compromised by trauma, caries or restorative procedures.” [14]. In this sense, VPT can involve directly (DPC) or indirectly capping the dental pulp (IPC), and full or partial pulpotomy [7, 15]. The success of VPT depends on the precise diagnosis and stage of inflammation, as well as selection of the pulp capping agent [16, 17]. The ideal pulp capping material should facilitate the formation of reparative dentin and the preservation of a vital dental pulp [18]. Several pulp capping agents have been introduced into the market (Table 1), offering various success rates, advantages, and disadvantages. While some materials, like calcium hydroxide (CH), are widely recognized for their affordability and long track record [19, 20], they lack long-term durability and ability to adhere to the dentin surface. In addition, CH has been widely criticized for the tunnel defect-like phenomena in the formed reparative dentin [2123], potentially leading to microleakage and bacterial invasion into the dental pulp [24]. To overcome the drawbacks of CH, calcium silicate cement-based materials were introduced such as MTA and MTA-derived materials. MTA was introduced as a therapeutic bioactive material that quickly gained popularity due to its’ biocompatibility, sealing ability, and excellent clinical success [2527]. However, MTA has several limitations such as high cost, long setting time, tooth discoloration and handling challenges. Based on this, a search for a newer generation of endodontic materials, introduced some enhanced derivatives of calcium silicate capping agents. Biodentine (Septodeont, Saint-Maur-des-Fosses, France), was developed as a dentin substitute [2830] and demonstrated success rates comparable to MTA in both short and long-term follow-up visits [19, 25, 3133], but with Biodentine exhibiting better handling properties and quicker setting time than MTA [34]. However, both MTA and Biodentine are supplied in powder/liquid form, which requires a separate mixing step before application. This could lead to inconsistent chemical and mechanical properties of the capping agent due to variabilities in the powder-to-liquid mixing ratios [35, 36].

Table 1:

Summary of common pulp capping materials:

Material Composition Advantages Disadvantages Setting type/time
Dycal
Pulpdent
Pulpcal
Base: Zinc oxide, calcium phosphate, calcium tungstate
Catalyst: Calcium hydroxide, zinc oxide and titanium dioxide.
Easy to work with, sets quickly.
Cost-effective [20].
Limited antibacterial activity over time [60]
Poor cohesive strength [61].
Greater solubility, and marginal leakage [62, 63].
Tunnel defect in formed reparative dentin [21, 22].
Self-curing
2–3 min
Cavit-G
Zinogen
Zinc oxide eugenol Reduces inflammation [64]. Releases eugenol even in low concentrations can be cytotoxic to dental pulp cells [65, 66] Self-curing
5–10 min setting continues for 1–2 hours
GIC
Fuji
Glass ionomer/Resin modified
glass ionomer
Excellent bacterial seal [67]
Fluoride release [68, 69].
Bond to both enamel and dentin.
Good biocompatibility [70].
Cytotoxic when in direct cell contact and lack of dentin bridge formation (41) [71]. Self-curing
3–5 min
Mineral trioxide aggregate (MTA) Tricalcium and dicalcium silicate, tricalcium aluminate, tricalcium and silicate oxides and bismuth oxide. Good biocompatibility [7, 27] More predictable hard tissue barrier formation than CH [72].
Antibacterial properties [73].
Osteoinductive [74].
Poor handling characteristics [75].
Long setting time [76].
Self-curing
30 min - 2 hours
Biodentine Powder: tricalcium silicate, calcium carbonate and zirconium oxide.
Liquid: water and calcium chloride.
Biocompatible [77].
Bond to deep moist dentin [32, 78]
Induces mineralized bridge formation [45].
Faster setting time and good physiochemical properties [28].
Shorter working time and limited radiopacity [79].
Difficulty in achieving the desired consistency.
Poor bonding with overlying restorations [80]
Self-curing
12 min
Theracal LC Calcium silicate, barium sulphate, barium zirconate, fumed silica, and Bis-GMA and PEGDMA resin. Low solubility and good mechanical properties [81].
Easy handlings, convenient and short setting time [82].
Induced dentin bridge formation [83].
Long-term efficacy is limited [84].
Higher cytotoxic effects and reduced cell viability [77].
Reduced radiopacity
Light-cured
10 sec
Premixed Bioceramics
(EndoSequence BC, TotalFill BC RRM, iRoot BP Plus)
Calcium silicate, zirconium oxide, calcium phosphate, calcium sulphate and fillers. Superior handling, uniform capping consistency and convenient manipulation [85].
Biocompatible [77] and ability to induce mineralization and odontoblast differentiation [40].
Limited long-term data [42].
Tooth discoloration [44].
Self-curing 15–20 min

To further improve handling and maneuverability in clinical settings, ready-to-use capping materials were developed such as Theracal LC (Bisco, Scaunburg, IL, USA) and premixed bioceramics such as iRoot BP Plus (Innovative Biocermaics, Vancouver, BC, Canada), TotalFill RRM putty (FKG, La-Chaux-de-Fonds, Switzerland) and EndoSequence BC putty (Brasseler, USA, Savannah, GA). Theracal LC is a hybrid, light-cured resin-modified calcium silicate material. The addition of the resin monomer provided some advantages such as enhanced physical properties, shorter setting time, and user-friendliness. Despite its advantages, there are concerns regarding the potential cytotoxic effects from residual resin monomers coming in contact with the dental pulp tissue [3739]. Regardless, premixed bioceramics have been shown to possess more favourable biocompatible properties in inducing reparative dentin formation due to their apatite-forming ability [40, 41]. Additional advantages have also been reported, including a uniform consistency, minimum technique sensitivity [42], antibacterial properties [43], and versatile applications [44]. These ready-made materials have been mostly tested as endodontic sealers and root canal obturation agents, and few studies have been conducted to evaluate these materials as pulp capping agents [42]. Furthermore, most studies have focused primarily on reparative dentin formation as the main outcome when evaluating calcium silicate-based capping agents [27, 31, 41, 45, 46] and have not assessed critical factors such as sealing efficiency and microleakage in vivo [4749]. This highlights a gap in understanding the biocompatibility and mechanical performance of currently available pulp capping agents and emphasizes the need to perform comprehensive analyses in preclinical models in vivo.

It is crucial to note that while human studies provide important evidence on materials performance, the analyses rely on two-dimensional radiographs, which lack the resolution to detect thin or early dentin bridge formation (<0.5 mm) [50]. Preclinical models allow for a multidimensional assessment of the healing response, such as the structural features of the dentin bridge. Rats are among the most widely used preclinical models for endodontic research due to their size, cost-effectiveness, and relatively straightforward handling in laboratory settings [5158]. However, rats do not provide the genetic flexibility that mice do to investigate the underlying cellular and molecular mechanisms driving tissue repair [59]. Despite these advantages in mice, their small mouth and tooth size make these procedures technically challenging, but surgical operating microscopes have improved the ability to perform endodontic and dental procedures in smaller animals. Therefore, the aim of this study is to refine a pulp capping technique in mice by testing three calcium silicate capping materials: Biodentine (BD), Bioceramic putty (BC) Putty, and Theracal LC (TLC). We assessed the materials’ effects on reparative dentin formation (via microCT and histology), and sealing quality (via void analysis). We hypothesized that comparing these materials head-to-head in a controlled mouse model would create conclusive evidence regarding their impact on dentin healing and better inform material selection and future preclinical and translational research in regenerative endodontics.

Materials and methods:

This study incorporated the Preferred Reporting Items for Animal studies in Endodontology (PRIASE) 2021 guidelines [86, 87].

Animals:

All mouse experiments were approved by the Institutional Animal Care and Use Committee (Protocol #2020A00000023-R1). Three-month-old wild-type (WT) C57BL/6 female mice weighing from 17 – 22g were used. To ensure ethical and responsible conduct of animal research, the number of mice in this study was minimized in accordance with the ARRIVE guidelines [88]. The mice were maintained by qualified caretakers in a sterile setting with controlled humidity, temperature, and lighting. We conducted the study using only female mice to minimize the gender effects on dentin healing.

Direct pulp capping procedure:

A total of 16 mice were randomly divided into 4 experimental groups (n=3–4 mice/group); CG, Cavit-iG (3M ESPE, St Paul, MN) with a collagen sponge (Zimmer Plug® and Optimaix 3D®), TLC, Theracal LC (Bisco, Schaumburg, IL, USA), BC, Bioceramic RRM putty (Brasseler USA, Savannah, GA), or BD, Biodentine (Septodont, Saint-Maur-des-Fossés, France). The mice were anesthetized with isoflurane and weighed before the experiment. We used a standardized mouse tooth injury model as described by Yang et al [89] in Figure 1A. A type ll or intermediate injury was performed involving the deep dentin with partial loss of pulpal tissue stimulating the formation of reparative dentin as part of the healing response [90]. The maxillary first molar was first disinfected with 70% ethanol and a cavity was drilled without exposure using a 0.3 mm round carbide bur (Komet, USA) on the mesial surface of both maxillary first molars with constant cooling. The mesial horn of the dental pulp was then exposed using #15 K endodontic file (Dentsply, Switzerland) with a pinpoint bleeding confirming the exposure, after which haemostasis was achieved using a sterile paper point. The exposure was capped with one of the four capping materials; CG, BC, BD or TLC, and then sealed with glass ionomer cement (Fuji IX, GC) as per the manufacture instructions (Figure 1B). Each capping material was applied in a single layer and allowed to set according to the manufacture instructions (Table 1). Excess material was removed, and the tooth and gingival tissues were cleaned with a cotton tip soaked in sterile distilled water. The mice were returned to their cages with no food for 30 minutes and then supplied with soft diet gel (W.F.Fisher and Son, USA) for 24 hours to minimize discomfort during mastication. The mice were maintained on standard chow and monitored for changes in eating behaviours. Weights were recorded at day 0- and 21-days post capping.

Figure 1: Experimental design and standardized pulp capping procedure:

Figure 1:

(A) Schematic representation of the experimental workflow and pulp capping technique using a standardized mouse tooth injury method. Maxillae samples were collected at two time points: Day 1 for immunofluorescence labelling of immune cells, and Day 21 for Micro-CT and histological analysis. (B) Sequential images of the pulp capping procedure. (1) Unprepared maxillary first molar in a mouse. (2) Cavity preparation using a 0.3 mm round bur, followed by pulp exposure with a #15K endodontic file. (3) Application of the pulp capping material over the exposed pulp tissue. (4) Placement of a glass ionomer restoration to seal the cavity. Standardized mouse tooth injury illustration adopted from Yang et al 2023. Illustration created with Biorender.

Micro-computed tomography (μCT):

The mice were sacrificed at 21 days post-capping using intracardiac perfusion buffered with 0.5M PB with 4% paraformaldehyde. Hemimaxillae were fixed in 4% paraformaldehyde for 2 hours at room temperature, followed by two rinses with PBS and transfer to 70% ethanol for micro-CT scanning (Scanco Medical, Brüttisellen, Switzerland) at 70 Kvp, 6 μm voxel dimension, 0.5 Al filter, and 1,200 ms integration time. Known density hydroxyapatite (HA) phantoms (0, 100, 200, 400, and 800 mg HA/cm3) were scanned at the same parameters and used to quantify a standard linear curve to formulate the density unit of each sample as mentioned in our previous article [91]. DICOM reconstructed files were analyzed with AnalyzePro 15.0 (AnalyzeDirect). The first maxillary molar and associated alveolar bones were segmented as regions of interest (ROI). The ROI was outlined as the area between 240 μm mesial from the most mesial point of the mesial maxillary first molar root and 240 μm distal from the most distal point of the distal maxillary molar root. Reparative dentin was manually segmented at 240–1,600 mg HA/cm3. Periodontal ligament (PDL) space of the mesial maxillary molar was manually segmented using the apical 1/3 of the total mesial root length. The sealing ability of the four capping materials was assessed by measuring the voids percentage in the capping materials. The capping material was outlined, and the voids were manually segmented at 2300–2811 mg HA/cm3. This range was selected to effectively exclude enamel from our analysis, as enamel possesses a significantly higher mineral density compared to dentin and other dental tissues. The total volume of each capping material and the internal void volume were quantified using high-resolution micro-CT. Segmentation was performed based on grayscale thresholding to differentiate between the capping material and voids. All measurements were conducted using consistent threshold values and image analysis parameters to ensure comparability across samples. The voids percentage of each capping material was calculated using the following equation: Voids percentage = (voids volume / total void + capping volume) X 100.

Histological examination:

The mice were sacrificed at 21 days post-capping using intracardiac perfusion buffered with 0.5M PB with 4% paraformaldehyde. Hemimaxillae were fixed in 4% paraformaldehyde for 2 hours at room temperature and decalcified in poly-Nocal (Polysciences) for 5–7 days. Tissues were then dehydrated and embedded in paraffin for 6 μm sections along the midsagittal axis. The sections were stained using Hematoxylin and eosin (H&E) and Masson’s Trichrome stains according to standard protocols and mounted with a mounting solution.

Statistical analysis

Mean ± standard deviation values were shown in the graphs. The normality test was achieved using Shapiro-Wilk test. Data were calculated with a one-way analysis of variance (ANOVA) test and Tukey’s multiple comparisons test to compare between the capping materials, where p = 0.05 or less was considered statistically significant. Data analysis was performed using statistical software (Prism 10.4.1; GraphPad Software). Sample size calculation was based on previous studies evaluating comparable outcomes [31, 41], with a significance level (α) of 0.05, and a desired power (1-β) of 0.8, the analysis indicated a total number of 16 mice (n=3–4 mice/group) with bilateral molars to be sufficient to detect statistically significant differences.

Results:

No adverse events occurred, nor any mice were lost during the experiments. A total of 16 mice (32 molars) were included in the final analysis.

Differential dentin bridge formation induced by calcium silicate-based pulp capping agents:

Micro-CT analysis was employed to assess the formation of tertiary dentin and the morphology of PDL space (Figure 2AH and 2L). At 21 days, we found that the CG group exhibited a statistically significant reduction in tertiary dentin formation compared to the other groups. Ectopic calcifications were observed in the CG cohort (see Figures 2A and 2I). A notable disparity in tertiary dentin volume was identified between the TLC group and the BD treated group (Figure 2I). No significant differences were detected in the density of tertiary dentin between experimental groups (Figure 2J). The analysis of the PDL space surrounding the apical one-third of the mesial roots was conducted to evaluate the inflammatory response elicited by each capping material. Interestingly, the CG restorations led to enlarged PDL space relative to the BC, BD, and untreated group. However, we did not find any significant difference between the untreated group and TLC, BC, and BD groups. This observation suggests that CG treatment induces pulpal inflammation (Figure 2KL) and (Figure 3AD).

Figure 2: Micro-CT analysis of reparative dentin formation and PDL widening at 21 days post-capping:

Figure 2:

(A,B) Cavit-G group (negative control) displaying signs of random opacities along the root canal. (C-H) representative 3D and 2D slices demonstrating reparative dentin (outlined in green) formed which appear denser and localized beneath the pulp capping material. Quantification of reparative dentin volume (I) and density (J) showing significant differences in pulp capping volume between each capping material; TLC, BC and BD with CG. No significant differences were observed in density between the four materials. Region of interest (ROI) for measuring PDL widening is represented in L. The PDL was manually segments at the apical 1/3 of the total mesial root length of the injured maxillary first molar. Quantification of the PDL widening presented in K, significant differences were observed between BD and CG, BC and CG, and UT (untreated) and CG. No significant differences were observed between the three capping materials (BC, TLC and BD) and UT group. Scalebars are 50μm in B. *P < 0.05, **P <0.01, *** P < 0.001 by one-way ANOVA. P: pulp, DE: dentin, EN: enamel, AB: alveolar bone, CG: Cavit-G, TLC: Theracal LC, BC: BC putty, BD: Biodentine.

Figure 3: Histopathological evaluation at day 21 post-capping using Hematoxylin-eosin and Masson trichrome staining.

Figure 3:

(A-D) Cavit-G group (negative control) displaying no evidence of reparative dentin, absence of odontoblasts and dental pulp cells, and extension of the inflammation along the mesial root canal. (E-H) Theracal – LC group. (I-L) BC putty group. (M-P) Biodentine group. Images E-P demonstrating reparative dentin formation indicated by the yellow arow in F, J and N. Scalebars = 200μm in A and C and = 50μm in B and D. P: dental pulp, DE: dentin, AB: alveolar bone.

Enhanced sealing ability with premixed calcium silicate-based pulp capping agents:

DPC with BD resulted in the highest material voids (mean = 13.4 %), with TLC pulp capped molars demonstrating 8.31% average void space, and BC pulp capped molars demonstrating an average of 6.39%. Significant differences in void percentage were found between the BD and BC groups (P = 0.008). No significant differences were found between TLC and BC in void percentage (Figure 4 AM). No significant differences were found in the total capping material volume between all the groups (P > 0.05). Figure 4 shows representative images of the total capping and void volume in 2D slices and 3D segmentation.

Figure 4: Micro-CT analysis of the sealing ability of the capping materials at 21 days post-capping.

Figure 4:

This illustration shows sagittal cross sections of the capped first maxillary molar presented in A,E and I. Trans axial 2D slices sectioned at the dashed yellow line in (B-K) displaying the total capping and void areas in TLC, BC and BD. 3D rendering of the three capping material (purple) and associated voids (blue). Quantification of the capping material volume (M) and voids % in (N) between the three capping materials (TLC, BC, and BD). Scalebars are 100μm. *P < 0.05, by one-way ANOVA. P: pulp, DE: dentin, AB: alveolar bone, CM: capping material, TLC: Theracal LC, BC: BC putty, BD: Biodentine.

Discussion:

In recent years, there has been a growing interest in VPT, as an alternative to RCT [9296]. Traditionally, the focus of VPT was primarily aimed at maintaining the vitality of the radicular dental pulp after minor injuries or caries exposure. This was typically indicated for primary teeth and immature permanent teeth with deep caries to allow continued root formation and apex closure [97]. Today, vital pulp therapy has evolved with a broader scope, no longer restricted to immature teeth. It is now a viable treatment option for mature permanent teeth, supported by advancements in biomaterials and minimally invasive techniques [5]. Despite the potential of vital pulp therapies to enhance the pulp’s healing in older adults, their reported success rates vary widely from 42.9% to 81.5%, and generally lower compared to full pulpectomy [23, 98]. This unpredictability hinders the widespread clinical adoption and success of VPTs, demanding further research to improve clinical outcomes. In response, bioengineers have made significant advances in biomaterials to enhance the biocompatibility and sealing outcomes of their pulp capping materials. As a result, MTA has largely replaced calcium hydroxide as the gold standard for direct pulp capping, due to its superior sealing ability, biocompatibility, and long-term clinical outcomes [26]. Newer calcium silicate-based cements were then developed to address the drawbacks associated with MTA, including its’ long setting time, difficult handling properties, discoloration, and relatively high cost. Materials such as Biodentine, BC Putty, and Theracal LC offer improved clinical usability through faster setting times, premixed formulations, and enhanced mechanical properties, while retaining the biological benefits of MTA. Despite promising in vitro and clinical data, variability in composition, setting mechanisms, and long-term outcomes have prevented direct comparisons between these newer materials to make informed decisions on material selection. Further preclinical research is essential to understand how each material and technique impacts sealing ability, pulp inflammation, and pulp healing.

Although calcium silicate-based materials have shown promising results in preclinical and in vitro studies [19, 25, 3133, 40, 41], translating these findings directly to clinical success in human teeth is not always straightforward. This is because studies are often conducted using different animal models (e.g., rats, dogs, or mice), which each have unique pulp anatomies, healing capacitates, and immune responses that differ significantly from human teeth [26, 59]. The choice of model depends on the specific research goals, ethical considerations, and resources available. This study focused on developing the techniques and materials in mice to allow for future studies utilizing transgenic mouse models with global and conditional deletion and/or overexpression of genes. Our study has established a standardized and reproducible technique for performing DPC in mice, enabling consistent assessment of pulp healing and material performance in a genetically tractable model.

In the present study, we focused on comparing three commercially available calcium silicate pulp capping agents to help guide evidence-based material selection and translate the findings into clinically reliable outcomes. Our study demonstrated that all three calcium-silicate-based materials induced reparative dentin formation by day 21, demonstrating their biocompatibility and capacity to support pulp healing. Significant differences in tertiary dentin volume were observed between the three calcium silicate materials and the Cavit-G control; however, no significant differences in dentin density were detected among any of the groups. Our findings are in alignment with previous studies evaluating calcium silicate-based materials as pulp capping agents [40, 45, 77, 83], further supporting their effectiveness in promoting reparative dentin formation and pulp healing.

A key factor for the success of VPT is achieving a well-adapted void free seal to prevent microleakage. An inadequate seal is a major cause of failure in endodontic procedures, as it allows bacterial penetration, leading to recurrent inflammation and compromised treatment outcomes [48, 49]. A material that promotes dentin formation but fails to provide an effective seal compromises pulp protection and thus would not be clinically viable for long-term performance. In this study, we evaluated the sealing ability of different capping materials by measuring the voids percentage. Biodentine exhibited higher voids percentage than BC putty and Theracal LC when combined with glass ionomer restorations, suggesting that the BC putty may offer superior sealing properties compared to the other materials, potentially reducing the risk of microleakage and associated complications. These findings are in agreement with prior studies assessing the sealing ability and microleakage of pulp capping materials [99104]. In an in vitro study, Makkar et al evaluated the sealing ability of Biodonetine and Theracal LC against the conventional MTA using confocal laser microscopy and Rhodamine B fluorescent dye. Both Biodentine and MTA showed comparable micropermeability at the material dentin interface. However, Theracal LC exhibited significantly higher sealing ability than the other two materials [99]. One possible explanation for the lower sealing ability of Biodentine, is the variability introduced by its powder-to-liquid mixing process, which may lead to inconsistencies in material properties compared to ready-to-use materials. On the contrary, Anusha et al compared the microleakage of Biodentine with Theracal PT; a newer dual-cured calcium silicate capping agent. Their findings demonstrated no significant differences in microleakage scores between the two capping materials [100]. Nevertheless, it should be emphasized that TheraCal PT was developed to improve the cytocompatibility of resin-based calcium silicate capping agents by reducing the resin content, in contrast to its predecessor, TheraCal LC [101]. While its cytotoxicity has been shown to be comparable to Biodentine [102, 103], the reduced resin content in TheraCal PT could potentially reduce its mechanical strength and sealing efficacy [104].

To the best of our knowledge, the sealing ability of BC putty as pulp capping agent has not been previously evaluated. De-Deus et al assessed the interfacial adaption and internal gaps of Endosequence BC as a root canal sealer compared with the epoxy resin-based AH Plus sealer. Although both groups demonstrated gaps at the interface, AH plus displayed better sealing adaptability than BC sealer [105]. Raju et al compared the apical sealing ability of ProRoot MTA, Biodentine and Total Fill BC as root end filling materials. TotalFill BC RRM Putty exhibited minimal microleakage along the root canal walls in vitro [106]. The literature remains inconsistent regarding the sealing ability of endodontic materials, attributed to the methodological differences across studies. In our study, we provide a novel method with which to quantify sealing ability and emphasize its ease-of-use with preclinical rodent models for the community of researchers involved in improving VPTs.

This present study contributes several data points to the growing body of evidence on calcium silicate-based materials as pulp capping agents. First, the study employed a standardized and reproducible pulp capping technique, ensuring uniform application of materials and minimizing procedural variability. All procedures were performed by a single trained investigator to ensure consistency and minimize inter-operator variability. Second, the combined use of micro-CT imaging and histological analysis for the quantification of reparative dentin volume, along with the sealing ability, offers a more nuanced understanding of material performance than studies relying on a single outcome measure. Thirdly, assessing the sealing efficacy of a pulp capping material can help predict the long-term success and durability of the VPT. Lastly, comparing three widely used calcium silicate materials head-to-head under identical experimental conditions, can be used to inform both preclinical researchers and clinicians on materials to utilize in their studies and practice.

This in vivo study was conducted in response to the inconsistency and lack of standardization in previous VPT research, particularly the use of varying animal models. Moreover, the sealing ability of these newer materials remains underexplored. Therefore, a standardized DPC mouse model was necessary to enable direct comparison. Nonetheless, this study has certain limitations. One limitation of this study is the use of sound healthy molar teeth rather than a pulpitis model. While mechanically exposed healthy pulps allow for controlled comparisons of reparative dentinogenesis and inflammation, they do not fully replicate the clinical environment where pulp capping is typically indicated. As such, the healing dynamics observed in this model may differ from those in a diseased state, potentially affecting the translational relevance of the findings. Additionally, while micro-CT provides a valuable volumetric assessment of voids and material placement, it does not capture the microscopic interaction between the capping material and dentinal surfaces [107, 108]. This includes adhesion at the dentin interface and penetration into dentinal tubules, which are critical for long-term sealing efficacy. Future studies should incorporate advanced techniques to better characterize capping material adaptation and bonding at the dentin interface and with the overlaying restoration.

Conclusions:

In this study, all three calcium-silicate-based pulp capping materials; Biodentine, BC Putty, and TheraCal LC successfully induced reparative dentin formation, demonstrating their biocompatibility and healing potential when compared to the negative control; Cavit-G. Among them, BC Putty and Theracal LC exhibited superior sealing ability, characterized by a greater extent of void-free areas, suggesting enhanced marginal adaptation. These findings highlight the importance of evaluating both biological and physical properties to inform the selection of pulp capping materials in clinical practice.

Funding:

These studies were funded by the NIH/NIDCR 1R03DE032355 to SBP.

Funding Statement

These studies were funded by the NIH/NIDCR 1R03DE032355 to SBP.

Footnotes

Conflicts of Interest: None

References:

  • 1.Bagramian R.A., Garcia-Godoy F., and Volpe A.R., The global increase in dental caries. A pending public health crisis. Am J Dent, 2009. 22(1): p. 3–8. [PubMed] [Google Scholar]
  • 2.Peres M.A., Oral diseases: a global public health challenge, Macpherson L.M.D., Editor. 2019: The Lancet. p. 249–260. [DOI] [PubMed] [Google Scholar]
  • 3.Kazeminia M., et al. , Dental caries in primary and permanent teeth in children’s worldwide, 1995 to 2019: a systemaBc review and meta-analysis. Head Face Med, 2020. 16(1): p. 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Goldberg M. and Lasfargues J.J., Pulpo-denBnal complex revisited. J Dent, 1995. 23(1): p. 15–20. [DOI] [PubMed] [Google Scholar]
  • 5.AAE PosiBon Statement on Vital Pulp Therapy. J Endod, 2021. 47(9): p. 1340–1344. [DOI] [PubMed] [Google Scholar]
  • 6.Bjørndal L. and Kidd E.A., The treatment of deep denBne caries lesions. Dent Update, 2005. 32(7): p. 402–4, 407–10, 413. [DOI] [PubMed] [Google Scholar]
  • 7.Ricucci D., et al. , Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure. J Dent, 2019. 86: p. 41–52. [DOI] [PubMed] [Google Scholar]
  • 8.Duncan H.F., et al. , Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical pracBce guideline. Int Endod J, 2023. 56 Suppl 3: p. 238–295. [DOI] [PubMed] [Google Scholar]
  • 9.Tavares P.B., et al. , Prevalence of apical periodonBBs in root canal-treated teeth from an urban French populaBon: influence of the quality of root canal fillings and coronal restoraBons. J Endod, 2009. 35(6): p. 810–3. [DOI] [PubMed] [Google Scholar]
  • 10.Fadhil N.H., et al. , Assessment of Treatment Quality Risk Factors Influencing the Radiographic DetecBon of Apical PeriodonBBs in Root-Filled Teeth: A RetrospecBve CBCT Analysis. Eur Endod J, 2024. 9(3): p. 252–259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Murray P.E., Garcia-Godoy F., and Hargreaves K.M., RegeneraBve endodonBcs: a review of current status and a call for acBon. J Endod, 2007. 33(4): p. 377–90. [DOI] [PubMed] [Google Scholar]
  • 12.Frencken J.E., et al. , Minimal intervenBon denBstry for managing dental caries - a review: report of a FDI task group. Int Dent J, 2012. 62(5): p. 223–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Morotomi T., Washio A., and Kitamura C., Current and future opBons for dental pulp therapy. Jpn Dent Sci Rev, 2019. 55(1): p. 5–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.(AAE), A.A.o.E., Glossary of endodonBc terms. American AssociaBon of EndodonBsts. Dec;2019. [Google Scholar]
  • 15.American AssoicaBon of EndodonBsts. Guide to Clinical EndodonBcs. 2013.
  • 16.Maltz M. and Alves L.S., Pulp capping material is an important prognosBc factor for direct pulp capping in permanent teeth. J Evid Based Dent Pract, 2013. 13(3): p. 117–9. [DOI] [PubMed] [Google Scholar]
  • 17.Cho S.Y., et al. , PrognosBc factors for clinical outcomes according to Bme aZer direct pulp capping. J Endod, 2013. 39(3): p. 327–31. [DOI] [PubMed] [Google Scholar]
  • 18.Cohen B.D. and Combe E.C., Development of new adhesive pulp capping materials. Dent Update, 1994. 21(2): p. 57–62. [PubMed] [Google Scholar]
  • 19.Cushley S., et al. , Efficacy of direct pulp capping for management of cariously exposed pulps in permanent teeth: a systemaBc review and meta-analysis. Int Endod J, 2021. 54(4): p. 556–571. [DOI] [PubMed] [Google Scholar]
  • 20.Zhu C., Ju B., and Ni R., Clinical outcome of direct pulp capping with MTA or calcium hydroxide: a systemaBc review and meta-analysis. Int J Clin Exp Med, 2015. 8(10): p. 17055–60. [PMC free article] [PubMed] [Google Scholar]
  • 21.Cox C.F., et al. , Tunnel defects in denBn bridges: their formaBon following direct pulp capping. Oper Dent, 1996. 21(1): p. 4–11. [PubMed] [Google Scholar]
  • 22.Amin L.E. and Montaser M., ComparaBve evaluaBon of pulpal repair aZer direct pulp capping using stem cell therapy and biodenBne: An animal study. Aust Endod J, 2021. 47(1): p. 11–19. [DOI] [PubMed] [Google Scholar]
  • 23.Rao Q., et al. , Comparison of iRoot BP Plus and Calcium Hydroxide as Pulpotomy Materials in Permanent Incisors with Complicated Crown Fractures: A RetrospecBve Study. J Endod, 2020. 46(3): p. 352–357. [DOI] [PubMed] [Google Scholar]
  • 24.Holland R., et al. , Permeability of the hard Bssue bridge formed aZer pulpotomy with calcium hydroxide: a histologic study. J Am Dent Assoc, 1979. 99(3): p. 472–5. [DOI] [PubMed] [Google Scholar]
  • 25.Care O. and Oznurhan F., EvaluaBon and comparison of mineral trioxide aggregate and biodenBne in primary tooth pulpotomy: Clinical and radiographic study. Niger J Clin Pract, 2017. 20(12): p. 1604–1609. [DOI] [PubMed] [Google Scholar]
  • 26.Andrei M., et al. , The Effect of Calcium-Silicate Cements on ReparaBve DenBnogenesis Following Direct Pulp Capping on Animal Models. Molecules, 2021. 26(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Alnour A., et al. , EvaluaBon of the pulp response following direct pulp capping with exogenous nitric oxide and Mineral Trioxide Aggregate (MTA) a histologic study. Heliyon, 2023. 9(7): p. e17458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Malkondu Ö., Karapinar Kazandağ M., and Kazazoğlu E., A review on biodenBne, a contemporary denBne replacement and repair material. Biomed Res Int, 2014. 2014: p. 160951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.StatPearls. 2025.
  • 30.About I., BiodenBne: from biochemical and bioacBve properBes to clinical applicaBons BiodenBne: dalle proprietà biochimiche e bioa_ve alle applicazioni cliniche. 2016, G. Ital. Endod. p. 81–88. [Google Scholar]
  • 31.Chae Y.K., Ye J.R., and Nam O.H., EvaluaBon of biocompaBbility and bioacBve potenBal of Well-Root PT by comparison with ProRoot MTA and BiodenBne. J Dent Sci, 2024. 19(4): p. 2218–2225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gangishei S., et al. , BioacBvity of Calcium Silicate-Based EndodonBc Materials: A ComparaBve. J Pharm Bioallied Sci, 2024. 16(Suppl 2): p. S1716–S1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Nowicka A., et al. , Response of human dental pulp capped with biodenBne and mineral trioxide aggregate. J Endod, 2013. 39(6): p. 743–7. [DOI] [PubMed] [Google Scholar]
  • 34.Al-Saudi K.W., A paradigm shiZ from calcium hydroxide to bioceramics in direct pulp capping: A narraBve review. J Conserv Dent Endod, 2024. 27(1): p. 2–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cavenago B.C., et al. , Influence of powder-to-water raBo on radiopacity, se_ng Bme, pH, calcium ion release and a micro-CT volumetric solubility of white mineral trioxide aggregate. Int Endod J, 2014. 47(2): p. 120–6. [DOI] [PubMed] [Google Scholar]
  • 36.Domingos Pires M., et al. , Effect of different manipulaBons on the physical, chemical and microstructural characterisBcs of BiodenBne. Dent Mater, 2021. 37(7): p. e399–e406. [DOI] [PubMed] [Google Scholar]
  • 37.Hebling J., et al. , Cytotoxicity of resin-based light-cured liners. Am J Dent, 2009. 22(3): p. 137–42. [PubMed] [Google Scholar]
  • 38.Bakhear H., et al. , Human Pulp Responses to ParBal Pulpotomy Treatment with TheraCal as Compared with BiodenBne and ProRoot MTA: A Clinical Trial. J Endod, 2017. 43(11): p. 1786–1791. [DOI] [PubMed] [Google Scholar]
  • 39.Jeanneau C., et al. , Light-cured Tricalcium Silicate Toxicity to the Dental Pulp. J Endod, 2017. 43(12): p. 2074–2080. [DOI] [PubMed] [Google Scholar]
  • 40.Mahgoub N., et al. , Comparison between iRoot BP Plus (EndoSequence Root Repair Material) and Mineral Trioxide Aggregate as Pulp-capping Agents: A SystemaBc Review. J Int Soc Prev Community Dent, 2019. 9(6): p. 542–552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Liu S., Wang S., and Dong Y., EvaluaBon of a bioceramic as a pulp capping agent in vitro and in vivo. J Endod, 2015. 41(5): p. 652–7. [DOI] [PubMed] [Google Scholar]
  • 42.Motwani N., et al. , Premixed bioceramics: A novel pulp capping agent. J Conserv Dent, 2021. 24(2): p. 124–129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Šimundić Munieć M., et al. , AnBmicrobial efficacy of commercially available endodonBc bioceramic root canal sealers: A systemaBc review. PLoS One, 2019. 14(10): p. e0223575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Prasad Kumara P.A.A.S., et al. , Bioceramics in EndodonBcs: LimitaBons and Future InnovaBons-A Review. Dent J (Basel), 2025. 13(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Minic S., et al. , EvaluaBon of Pulp Repair aZer BiodenBne. Biomedicines, 2021. 9(7). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bui A.H. and Pham K.V., EvaluaBon of ReparaBve DenBne Bridge FormaBon aZer Direct Pulp Capping with BiodenBne. J Int Soc Prev Community Dent, 2021. 11(1): p. 77–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Al Tuwirqi A.A., et al. , Tomographic EvaluaBon of the Internal AdaptaBon for Recent Calcium Silicate-Based Pulp Capping Materials in Primary Teeth. Biomed Res Int, 2021. 2021: p. 5523145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Patel C., et al. , EvaluaBon of Microleakage and Shear Bond Strength of Two Different Calcium-based Silicate Indirect Pulp Capping Agents When Restored with Glass Ionomer Cement and Composite Resin RestoraBon: A ComparaBve. Int J Clin Pediatr Dent, 2024. 17(9): p. 1035–1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Makkar S., <h1 data-test-id=“paper-detail-Btle” style=“box-sizing: border-box; font-family: “Roboto Slab”, Georgia, serif; font-size: 30px; line-height: 32px; margin: 0px 0px 5px; color: rgb(46, 55, 67); background-color: rgb(235, 236, 237);”>A Confocal Laser Scanning Microscopic Study EvaluaBng the Sealing Ability of Mineral Trioxide Aggregate, BiodenBne and Anew Pulp Capping Agent-Theracal. 2015.
  • 50.De Rossi A., et al. , Comparison of pulpal responses to pulpotomy and pulp capping with biodenBne and mineral trioxide aggregate in dogs. J Endod, 2014. 40(9): p. 1362–9. [DOI] [PubMed] [Google Scholar]
  • 51.Dammaschke T., Rat molar teeth as a study model for direct pulp capping research in denBstry. Lab Anim, 2010. 44(1): p. 1–6. [DOI] [PubMed] [Google Scholar]
  • 52.Islam R., et al. , Direct pulp capping procedures - Evidence and pracBce. Jpn Dent Sci Rev, 2023. 59: p. 48–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Islam M.R.R., et al. , Biological evaluaBon of novel phosphorylated pullulan-based calcium hydroxide formulaBons as direct pulp capping materials: An in vivo study on a rat model. Int Endod J, 2024. 57(9): p. 1247–1263. [DOI] [PubMed] [Google Scholar]
  • 54.Chung M., et al. , Inflammatory response and odontogenic differenBaBon of inflamed dental pulp treated with different pulp capping materials: An in vivo study. Int Endod J, 2023. 56(9): p. 1118–1128. [DOI] [PubMed] [Google Scholar]
  • 55.Tran X.V., et al. , Effect of a calcium-silicate-based restoraBve cement on pulp repair. J Dent Res, 2012. 91(12): p. 1166–71. [DOI] [PubMed] [Google Scholar]
  • 56.Gala-Garcia A., et al. , Bioceramic/poly (glycolic)-poly (lacBc acid) composite induces mineralized barrier aZer direct capping of rat tooth pulp Bssue. Braz Oral Res, 2010. 24(1): p. 8–14. [DOI] [PubMed] [Google Scholar]
  • 57.MAURICE C.G. and SCHOUR I., Experimental cavity preparaBons in the molar of the rat. J Dent Res, 1955. 34(3): p. 429–34. [DOI] [PubMed] [Google Scholar]
  • 58.BERMAN D.S. and MASSLER M., Experimental pulpotomies in rat molars. J Dent Res, 1958. 37(2): p. 229–42. [DOI] [PubMed] [Google Scholar]
  • 59.Aubeux D., Review of Animal Models to Study Pulp InflammaBon, Renard E., Editor. 2021. [Google Scholar]
  • 60.Coogan M.M. and Creaven P.J., AnBbacterial properBes of eight dental cements. Int Endod J, 1993. 26(6): p. 355–61. [DOI] [PubMed] [Google Scholar]
  • 61.Cox C.F., et al. , BiocompaBbility of primer, adhesive and resin composite systems on non-exposed and exposed pulps of non-human primate teeth. Am J Dent, 1998. 11 Spec No: p. S55–63. [PubMed] [Google Scholar]
  • 62.Goldberg M., Njeh A., and Uzunoglu E., Is Pulp InflammaBon a Prerequisite for Pulp Healing and RegeneraBon? Mediators Inflamm, 2015. 2015: p. 347649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Taira Y., et al. , Direct pulp capping effect with experimentally developed adhesive resin systems containing reparaBve denBn-promoBng agents on rat pulp: mixed amounts of addiBves and their effect on wound healing. Odontology, 2011. 99(2): p. 135–47. [DOI] [PubMed] [Google Scholar]
  • 64.Banoee M., et al. , ZnO nanoparBcles enhanced anBbacterial acBvity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J Biomed Mater Res B Appl Biomater, 2010. 93(2): p. 557–61. [DOI] [PubMed] [Google Scholar]
  • 65.Hume W.R., The pharmacologic and toxicological properBes of zinc oxide-eugenol. J Am Dent Assoc, 1986. 113(5): p. 789–91. [DOI] [PubMed] [Google Scholar]
  • 66.Escobar-García M., et al. , Eugenol Toxicity in Human Dental Pulp Fibroblasts of Primary Teeth. J Clin Pediatr Dent, 2016. 40(4): p. 312–8. [DOI] [PubMed] [Google Scholar]
  • 67.Alomari Q.D., Reinhardt J.W., and Boyer D.B., Effect of liners on cusp deflecBon and gap formaBon in composite restoraBons. Oper Dent, 2001. 26(4): p. 406–11. [PubMed] [Google Scholar]
  • 68.Nakade O., et al. , SBmulaBon by low concentraBons of fluoride of the proliferaBon and alkaline phosphatase acBvity of human dental pulp cells in vitro. Arch Oral Biol, 1999. 44(1): p. 89–92. [DOI] [PubMed] [Google Scholar]
  • 69.Thaweboon S., et al. , Effect of fluoride on human dental pulp cells in vitro. Southeast Asian J Trop Med Public Health, 2003. 34(4): p. 915–8. [PubMed] [Google Scholar]
  • 70.Mitra S.B., et al. , Long-term adhesion and mechanism of bonding of a paste-liquid resin-modified glass-ionomer. Dent Mater, 2009. 25(4): p. 459–66. [DOI] [PubMed] [Google Scholar]
  • 71.Bakopoulou A., Papadopoulos T., and Garefis P., Molecular toxicology of substances released from resin-based dental restoraBve materials. Int J Mol Sci, 2009. 10(9): p. 3861–3899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Suhag K., et al. , Success of Direct Pulp Capping Using Mineral Trioxide Aggregate and Calcium Hydroxide in Mature Permanent Molars with Pulps Exposed during Carious Tissue Removal: 1-year Follow-up. J Endod, 2019. 45(7): p. 840–847. [DOI] [PubMed] [Google Scholar]
  • 73.Torabinejad M., et al. , Physical and chemical properBes of a new root-end filling material. J Endod, 1995. 21(7): p. 349–53. [DOI] [PubMed] [Google Scholar]
  • 74.Okiji T. and Yoshiba K., ReparaBve denBnogenesis induced by mineral trioxide aggregate: a review from the biological and physicochemical points of view. Int J Dent, 2009. 2009: p. 464280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Johnson B.R., ConsideraBons in the selecBon of a root-end filling material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999. 87(4): p. 398–404. [DOI] [PubMed] [Google Scholar]
  • 76.Asgary S., et al. , The properBes of a new endodonBc material. J Endod, 2008. 34(8): p. 990–3. [DOI] [PubMed] [Google Scholar]
  • 77.Poggio C., et al. , In vitro cytotoxicity evaluaBon of different pulp capping materials: a comparaBve study. Arh Hig Rada Toksikol, 2015. 66(3): p. 181–8. [DOI] [PubMed] [Google Scholar]
  • 78.Han L. and Okiji T., Uptake of calcium and silicon released from calcium silicate-based endodonBc materials into root canal denBne. Int Endod J, 2011. 44(12): p. 1081–7. [DOI] [PubMed] [Google Scholar]
  • 79.Tanalp J., et al. , Comparison of the radiopaciBes of different root-end filling and repair materials. ScieneficWorldJournal, 2013. 2013: p. 594950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Arandi N.Z. and Thabet M., Minimal IntervenBon in DenBstry: A Literature Review on BiodenBne as a BioacBve Pulp Capping Material. Biomed Res Int, 2021. 2021: p. 5569313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Bakir E.P., et al. , Are resin-containing pulp capping materials as reliable as tradiBonal ones in terms of local and systemic biological effects? Dent Mater J, 2022. 41(1): p. 78–86. [DOI] [PubMed] [Google Scholar]
  • 82.Zhang L., et al. , Clinical influencing factors of vital pulp therapy on pulpiBs permanent teeth with 2 calcium silicate-based materials: A randomized clinical trial. Medicine (Balemore), 2024. 103(18): p. e38015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Cannon M., et al. , Primate pulpal healing aZer exposure and TheraCal applicaBon. J Clin Pediatr Dent, 2014. 38(4): p. 333–7. [DOI] [PubMed] [Google Scholar]
  • 84.Mahapatra J., et al. , ComparaBve EvaluaBon of the Efficacy of TheraCal LC, Mineral Trioxide Aggregate, and BiodenBne As Direct Pulp Capping Materials in PaBents With Pulpal Exposure in Posterior Teeth: A Triple-Blinded Randomized Parallel Group Clinical Trial. Cureus, 2024. 16(2): p. e55022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Song M., et al. , Chemomechanical ProperBes and BiocompaBbility of Various Premixed Puoy-type BioacBve Ceramic Cements. J Endod, 2023. 49(12): p. 1713–1721. [DOI] [PubMed] [Google Scholar]
  • 86.Nagendrababu V. and H Dummer P.M., Preferred ReporBng Items for study Designs in Endodontology (PRIDE): Guiding authors to produce high-quality manuscripts. J Conserv Dent, 2020. 23(4): p. 320–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Nagendrababu V., et al. , PRIASE 2021 guidelines for reporBng animal studies in Endodontology: explanaBon and elaboraBon. Int Endod J, 2021. 54(6): p. 858–886. [DOI] [PubMed] [Google Scholar]
  • 88.Kilkenny C., et al. , Improving bioscience research reporBng: the ARRIVE guidelines for reporBng animal research. Osteoarthries Carelage, 2012. 20(4): p. 256–60. [DOI] [PubMed] [Google Scholar]
  • 89.Yang D., Solidum J.G.N., and Park D., Dental Pulp Stem Cells and Current in vivo Approaches to Study Dental Pulp Stem Cells in Pulp Injury and RegeneraBon. J Bone Metab, 2023. 30(3): p. 231–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Byers M.R. and Närhi M.V., Dental injury models: experimental tools for understanding neuroinflammatory interacBons and polymodal nociceptor funcBons. Crit Rev Oral Biol Med, 1999. 10(1): p. 4–39. [DOI] [PubMed] [Google Scholar]
  • 91.Chavez M.B., et al. , Guidelines for Micro-Computed Tomography Analysis of Rodent Dentoalveolar Tissues. JBMR Plus, 2021. 5(3): p. e10474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Solomon R.V., et al. , Coronal Pulpotomy Technique Analysis as an AlternaBve to Pulpectomy for Preserving the Tooth Vitality, in the Context of Tissue RegeneraBon: A Correlated Clinical Study across 4 Adult Permanent Molars. Case Rep Dent, 2015. 2015: p. 916060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Bjørndal L., et al. , Management of deep caries and the exposed pulp. Int Endod J, 2019. 52(7): p. 949–973. [DOI] [PubMed] [Google Scholar]
  • 94.Asgary S., et al. , Five-year results of vital pulp therapy in permanent molars with irreversible pulpiBs: a non-inferiority mulBcenter randomized clinical trial. Clin Oral Inveseg, 2015. 19(2): p. 335–41. [DOI] [PubMed] [Google Scholar]
  • 95.Cushley S., et al. , Pulpotomy for mature carious teeth with symptoms of irreversible pulpiBs: A systemaBc review. J Dent, 2019. 88: p. 103158. [DOI] [PubMed] [Google Scholar]
  • 96.Philip N. and Suneja B., Minimally invasive endodonBcs: a new era for pulpotomy in mature permanent teeth. Br Dent J, 2022. 233(12): p. 1035–1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Cvek M., A clinical report on parBal pulpotomy and capping with calcium hydroxide in permanent incisors with complicated crown fracture. J Endod, 1978. 4(8): p. 232–7. [DOI] [PubMed] [Google Scholar]
  • 98.Gudkina J., et al. , Review of the success of pulp exposure treatment of cariously and traumaBcally exposed pulps in immature permanent incisors and molars. Stomatologija, 2012. 14(3): p. 71–80. [PubMed] [Google Scholar]
  • 99.Makkar S., A Confocal Laser Scanning Microscopic Study EvaluaBng the Sealing Ability of Mineral Trioxide Aggregate, BiodenBne and Anew Pulp Capping Agent-Theracal, Kaur H., Editor. 2015: Dental Journal of Advance Studies. [Google Scholar]
  • 100.Anusha B., et al. , EvaluaBon of Sealing Ability of BiodenBne and TheraCal PT in Primary Molars. Int J Clin Pediatr Dent, 2024. 17(2): p. 158–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Wassel M., Hamdy D., and Elghazawy R., EvaluaBon of four vital pulp therapies for primary molars using a dual-cured tricalcium silicate (TheraCal PT): one-year results of a non-randomized clinical trial. J Clin Pediatr Dent, 2023. 47(2): p. 10–22. [DOI] [PubMed] [Google Scholar]
  • 102.Novotná B., et al. , EvaluaBon of Cytotoxicity of the Dental Materials TheraCal LC, TheraCal PT, ApaCal ART and BiodenBne Used in Vital Pulp Therapy: In Vitro Study. Dent J (Basel), 2024. 12(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Park S.H., et al. , BiocompaBbility and BioacBvity of a Dual-Cured Resin-Based Calcium Silicate Cement: In Vitro and in vivo EvaluaBon. J Endod, 2024. 50(2): p. 235–242. [DOI] [PubMed] [Google Scholar]
  • 104.Topbaş C. and Kul A.K., Can flowable short-fiber-reinforced resins achieve a strong adhesion to bioceramics? Microsc Res Tech, 2024. 87(12): p. 2964–2973. [DOI] [PubMed] [Google Scholar]
  • 105.De-Deus G., et al. , Micro-CT assessment of gap-containing areas along the gutta-percha-sealer interface in oval-shaped canals. Int Endod J, 2022. 55(7): p. 795–807. [DOI] [PubMed] [Google Scholar]
  • 106.Raju N., A study to evaluate and compare the apical sealing ability of MTA, BiodenBne, and TotalFill BC RRM Puoy in simulated immature teeth. [Google Scholar]
  • 107.Toia C.C., et al. , Filling ability of three bioceramic root-end filling materials: A micro-computed tomography analysis. Aust Endod J, 2020. 46(3): p. 424–431. [DOI] [PubMed] [Google Scholar]
  • 108.Jung M., Lommel D., and Klimek J., The imaging of root canal obturaBon using micro-CT. Int Endod J, 2005. 38(9): p. 617–26. [DOI] [PubMed] [Google Scholar]

Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES